Literature DB >> 7778269

Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins.

R A Fridell1, L S Harding, H P Bogerd, B R Cullen.   

Abstract

Transcriptional activation of HIV-1 gene expression by the viral Tat protein requires the interaction of a cellular cofactor with the Tat activation domain. This domain has been shown to consist of the cysteine-rich and core motifs of HIV-1 Tat and is functionally conserved in the distantly related Tat proteins of HIV-2 and EIAV. Using the yeast two-hybrid system, we have identified a novel human gene product, termed HT2A, that specifically and precisely binds to the activation domain of HIV-1 Tat and that can also interact with the HIV-2 and EIAV Tat proteins in vivo. We present data further demonstrating that the interaction between the activation domain of HIV-1 Tat and the HT2A protein can be readily detected in the mammalian cell nucleus. Sequence analysis demonstrates that HT2A is a novel member of the C3HC4 or ring finger family of zinc finger proteins that includes several known oncogenes and transcription factors. Overall, these data suggest that HT2A may play a significant role in mediating the biological activity of the HIV-1 Tat protein in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7778269     DOI: 10.1006/viro.1995.1266

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  46 in total

1.  Drosophila Brain Tumor is a translational repressor.

Authors:  J Sonoda; R P Wharton
Journal:  Genes Dev       Date:  2001-03-15       Impact factor: 11.361

2.  CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription.

Authors:  C Suñé; T Hayashi; Y Liu; W S Lane; R A Young; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription.

Authors:  H Xiao; Y Tao; J Greenblatt; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

4.  Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm.

Authors:  M J Orsini; C M Debouck
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Utilization of a mammalian cell-based RNA binding assay to characterize the RNA binding properties of picornavirus 3C proteinases.

Authors:  W S Blair; T B Parsley; H P Bogerd; J S Towner; B L Semler; B R Cullen
Journal:  RNA       Date:  1998-02       Impact factor: 4.942

6.  MicroRNA-155 Reinforces HIV Latency.

Authors:  Debbie S Ruelas; Jonathan K Chan; Eugene Oh; Amy J Heidersbach; Andrew M Hebbeler; Leonard Chavez; Eric Verdin; Michael Rape; Warner C Greene
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

7.  Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene.

Authors:  Patrick Frosk; Tracey Weiler; Edward Nylen; Thangirala Sudha; Cheryl R Greenberg; Kenneth Morgan; T Mary Fujiwara; Klaus Wrogemann
Journal:  Am J Hum Genet       Date:  2002-01-29       Impact factor: 11.025

8.  gC1q-R/p32, a C1q-binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes.

Authors:  L Braun; B Ghebrehiwet; P Cossart
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

9.  Different subcellular localisations of TRIM22 suggest species-specific function.

Authors:  Anna-Maria Herr; Ralf Dressel; Lutz Walter
Journal:  Immunogenetics       Date:  2009-02-11       Impact factor: 2.846

10.  Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat.

Authors:  P D Bieniasz; T A Grdina; H P Bogerd; B R Cullen
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.